MAP1LC3A and breast cancer: In addition, we have reported a high degree of co-localisation between LC3 and mitochondrial markers in dormant BC cells together with a decrease in mitochondrial membrane potential and an increase in mitochondrial ROS and mitochondrial mass in dormant BC cells treated with HCQ as compared with their non-treated counterparts.